Beetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
Indian Health Service, Joslin Vision Network National Reading Center, Phoenix, Arizona.
Ophthalmology. 2016 Jun;123(6):1360-7. doi: 10.1016/j.ophtha.2016.01.043. Epub 2016 Mar 2.
To compare diabetic retinopathy (DR) identification and ungradable image rates between nonmydriatic ultrawide field (UWF) imaging and nonmydriatic multifield fundus photography (NMFP) in a large multistate population-based DR teleophthalmology program.
Multiple-site, nonrandomized, consecutive, cross-sectional, retrospective, uncontrolled imaging device evaluation.
Thirty-five thousand fifty-two eyes (17 526 patients) imaged using NMFP and 16 218 eyes (8109 patients) imaged using UWF imaging.
All patients undergoing Joslin Vision Network (JVN) imaging with either NMFP or UWF imaging from May 1, 2014, through August 30, 2015, within the Indian Health Service-JVN program, which serves American Indian and Alaska Native communities at 97 sites across 25 states, were evaluated. All retinal images were graded using a standardized validated protocol in a centralized reading center.
Ungradable rate for DR and diabetic macular edema (DME).
The ungradable rate per patient for DR and DME was significantly lower with UWF imaging compared with NMFP (DR, 2.8% vs. 26.9% [P < 0.0001]; DME, 3.8% vs. 26.2% [P < 0.0001]). Identification of eyes with either DR or referable DR (moderate nonproliferative DR or DME or worse) was increased using UWF imaging from 11.7% to 24.2% (P < 0.0001) and from 6.2% to 13.6% (P < 0.0001), respectively. In eyes with DR imaged with UWF imaging (n = 3926 eyes of 2402 patients), the presence of predominantly peripheral lesions suggested a more severe level of DR in 7.2% of eyes (9.6% of patients).
In a large, widely distributed DR ocular telehealth program, as compared with NMFP, nonmydriatic UWF imaging reduced the number of ungradable eyes by 81%, increased the identification of DR nearly 2-fold, and identified peripheral lesions suggesting more severe DR in almost 10% of patients, thus demonstrating significant benefits of this imaging method for large DR teleophthalmology programs.
在一个大型多州基于人群的糖尿病视网膜病变(DR)远程眼科项目中,比较非散瞳超广角(UWF)成像和非散瞳多视野眼底照相术(NMFP)在 DR 识别和不可评估图像率方面的差异。
多地点、非随机、连续、横断面、回顾性、非对照成像设备评估。
35052 只眼(17526 例患者)接受 NMFP 成像,16218 只眼(8109 例患者)接受 UWF 成像。
所有在印第安卫生服务-JVN 项目中接受 JVN 成像的患者均于 2014 年 5 月 1 日至 2015 年 8 月 30 日期间接受 NMFP 或 UWF 成像,该项目服务于美国印第安人和阿拉斯加原住民社区,遍布 25 个州的 97 个地点。所有视网膜图像均使用标准化的验证协议在集中阅读中心进行分级。
DR 和糖尿病性黄斑水肿(DME)的不可评估率。
与 NMFP 相比,UWF 成像的 DR 和 DME 患者不可评估率显著降低(DR,2.8%比 26.9%[P<0.0001];DME,3.8%比 26.2%[P<0.0001])。使用 UWF 成像可分别将 DR 或可转诊 DR(中度非增生性 DR 或 DME 或更严重)的检出率从 11.7%提高到 24.2%(P<0.0001)和从 6.2%提高到 13.6%(P<0.0001)。在接受 UWF 成像的 DR 眼(2402 例患者的 3926 只眼)中,7.2%(9.6%的患者)的眼底周边病变提示 DR 程度更严重。
在一个大型、广泛分布的 DR 眼部远程健康项目中,与 NMFP 相比,非散瞳超广角成像可将不可评估眼的数量减少 81%,DR 的检出率提高近 2 倍,并可发现近 10%的患者提示更严重 DR 的眼底周边病变,因此表明这种成像方法对大型 DR 远程眼科项目具有显著优势。